Literature DB >> 9089957

A model for interval-censored tuberculosis outbreak data.

P J Smith1, T J Thompson, J A Jereb.   

Abstract

As the incidence of tuberculosis (TB) has increased in the United States, occupationally acquired TB has increased among the health care workers (HCWs). This paper describes a model developed in response to the needs of an outbreak of multidrug-resistant TB. One of the goals of the outbreak investigation was to estimate the risk of tuberculin skin test (TST) conversion as a function of HCW job type and the period during which persons were employed over the study period. TST conversions were evaluated at periodic examinations and data are interval-censored. We present a generalized linear model that extends Efron's survival model for censored survival data to the case of interval-censored data.

Entities:  

Mesh:

Year:  1997        PMID: 9089957     DOI: 10.1002/(sici)1097-0258(19970315)16:5<485::aid-sim422>3.0.co;2-#

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study.

Authors:  Christothea Constandinou-Williams; Stuart I Collins; Sally Roberts; Lawrence S Young; Ciaran B J Woodman; Paul G Murray
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

2.  Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.

Authors:  Jim Young; Martin Rickenbach; Alexandra Calmy; Enos Bernasconi; Cornelia Staehelin; Patrick Schmid; Matthias Cavassini; Manuel Battegay; Huldrych F Günthard; Heiner C Bucher
Journal:  BMC Infect Dis       Date:  2015-09-21       Impact factor: 3.090

3.  Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study.

Authors:  Stuart Collins; Terry P Rollason; Lawrence S Young; Ciaran B J Woodman
Journal:  Eur J Cancer       Date:  2009-10-12       Impact factor: 9.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.